Market Overview

PulsePoint Launches Charitable Campaign to Promote Clinical Research as a Care Option


the leading global authority in programmatic technology, content
marketing and health activation, today announced a month-long charitable
campaign to promote awareness and education around clinical trials.
PulsePoint is on a mission to achieve better health outcomes for the
world's population through technology and data. A key element in driving
health outcomes is supporting clinical research and product innovation.
In recognition of International Clinical Trials Day, PulsePoint is
launching a three-part community education and outreach initiative
around clinical trials.

  • Over the course of a month, PulsePoint will donate use of its
    programmatic technology to promote three clinical trial public
    education campaigns: One
    Person Closer by TransCelerate
    , MT
    Pharmacy by Langland
    and CISCRP and Clara Health's "Patients
    Have Power
    " campaigns. All three campaigns use the power of
    storytelling to help raise awareness around the importance of clinical
    trials, educate and empower communities. Programmatic health
    technology is an efficient way to get specific messages out on media
    to people who will be interested in them in a targeted way.
  • On May 31, 2018, PulsePoint will host a gala celebrating the Popup
    contest. Popup Star is an annual multi-stakeholder,
    community-based competition to promote clinical research as a care
    option. The Popup Star winner will be announced at the gala, taking
    place at PulsePoint's NYC headquarters.
  • In addition, PulsePoint teams will donate time to canvas New York and
    San Francisco neighborhoods to help raise awareness of programs
    dedicated to accelerating research and improving health.

Clinical trial operators report major challenges in patient recruitment
and retention. It has been estimated that almost 80 percent of trials
fail to meet their enrollment timelines. This is because few eligible
candidates are aware that clinical trials are a therapeutic option, so
they are not proactively searching for relevant clinical trials. To date
roughly 56 million clinical trial seats are open globally.

"Programmatic technology has the power to help bring clinical research
to the forefront for the patients who stand to benefit," said PulsePoint
CEO, Sloan Gaon. "With big data and digital access to the world's
population, we reach very specific patient populations in the specific
geographies where trials are available, intervene meaningfully to
educate them about the pros and cons of clinical trials and get them to
think differently about trials and help them get connected and screened."

"We can't expect to bring the promise of research to all until we
recognize that health literacy is a human right," said Angela Radcliffe,
GM of Clinical Trial Solutions. "People don't know what they don't know
and when it comes to health, people's lives are at stake. This outreach
will meet people where they are and empower them to take action."

The news follows the company's recent announcement regarding the release
of Genome
by PulsePoint™, a comprehensive data platform that unifies clinical and
real-world data to break down the barriers between customer knowledge,
customer experiences, marketing impact and health outcomes to achieve
radical health personalization, putting consumers in the center of all
health outreach.

About PulsePoint

PulsePoint, a global programmatic advertising platform with specialized
healthcare expertise, fuses the science of programmatic targeting,
distribution and optimization with the art of brand engagement. The
PulsePoint platform is powered by terabytes of impression-level data,
allowing brands to efficiently engage the right audiences at scale while
helping publishers increase yield through actionable insights. Investors
in the company include Draper Fisher Jurvetson (DFJ), Gotham Ventures,
New Atlantic Ventures (NAV), Patricia Industries, Updata Partners and
VantagePoint Capital Partners. The company is headquartered in New York
City with offices in San Francisco, California, and London, U.K. Learn
more about PulsePoint here.

View Comments and Join the Discussion!